Ocugen stock gains says EU backs U.S. trial for gene therapy

Published on 10 Apr 2024 on Seeking Alpha

Ocugen (OCGN) stock gains as company wins EU nod for a U.S. trial for its gene therapy candidate,...

Read the rest of the article

Start tracking your investments with Statfolio

On September 30, 2024, State Street Corp made a significant addition to its investment portfolio ...

GuruFocus.com · via Yahoo Finance 18 Oct 2024

Ocugen Inc (OCGN) extends its financial runway with successful fundraising and regulatory...

GuruFocus.com · via Yahoo Finance 11 Oct 2024

The Medical group has plenty of great stocks, but investors should always be looking for companie...

Zacks · via Yahoo Finance 7 Jun 2024

Ocugen, Inc. OCGN is having a phenomenal run in the year so far. Shares of the company have...

Zacks · via Yahoo Finance 23 May 2024

Ocugen, Inc. OCGN is likely to provide updates on its pipeline developments when it reports first...

Zacks via Yahoo Finance 26 Apr 2024

Investing.com 11 Apr 2024

Ocugen (OCGN) stock gains as company wins EU nod for a U.S. trial for its gene therapy candidate,...

Seeking Alpha 10 Apr 2024

Ocugen, Inc. ( NASDAQ : NASDAQ: OCGN ), a biotechnology company specializing in gene and cell the...

Investing.com 10 Apr 2024

Ocugen, Inc. OCGN announced that the Data and Safety Monitoring Board (“DSMB”) for the early to m...

Zacks via Yahoo Finance 8 Apr 2024

Ocugen, Inc. OCGN shares are trading higher Friday after the company announced it has received ap...

Benzinga 5 Apr 2024